Apex Pharma VRTX has outperformed the market by 12.09% on an annualized basis over the past 10 years and has produced a compound annual return of 23.11%. Currently, Vertex Pharmaceuticals has a market cap of $81.16 billion.

Buy $1000 in VRTX: If an investor bought $1,000 worth of VRTX stock 10 years ago, it would be worth it $7,907.95 today based on a price of $316.16 for VRTX at the time of writing.

Vertex Pharmaceuticals’ performance over the past 10 years

Finally – what is all this? The most important takeaway to take from this article is how much of a difference compound returns can make in your cash growth over a period of time.

This article was created by Benzinga’s automated content engine and reviewed by an editor.